Answers are grounded in this paper and cite their sources.
Cohort analysis shows similar rates of sars-cov-2 breakthrough infection in people with and without hiv, suggesting vaccination effectiveness.
We found that risk of SARS-CoV-2 breakthrough infection did not meaningfully differ between a population-based cohort of vaccinated people with HIV and a matched cohort of people without HIV after accounting for sociodemographic factors, previous SARS-CoV-2 infection, SARS-CoV-2 testing patterns and COVID-19 vaccine doses (14 December 2020 to 5 May 2024). However, rates of breakthrough infection were higher among men with HIV compared to without HIV during the pre-Omicron era.
No takes yet. Share an insight, caveat, or question.
Freitas et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: